Prognostic Factors and Treatment Outcomes for Early-Stage Hodgkin Lymphoma in Cape Town, South Africa - Top-Institutions - MDSpire

Prognostic Factors and Treatment Outcomes for Early-Stage Hodgkin Lymphoma in Cape Town, South Africa

  • By

  • Shakira Dawood

  • Brigid McMillan

  • Karryn Brown

  • Jenna Oosthuizen

  • David Richardson

  • Kudakwashe Simba

  • Lillian F. Andera

  • Jessica Opie

  • Katherine Antel

  • Stuart More

  • Ayesha Allie

  • Zainab Mohamed

  • Estelle Verburgh

  • November 25, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    University of Cape Town and Groote Schuur Hospital
    University of Cape Town and Groote Schuur Hospital

    Cape Town, Western Cape

    Key Differentiators

    • Hematology
    • Oncology
    • Infectious Diseases

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Oncology
    • Radiation Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Infectious Diseases

  • #4

    National Cancer Institute (NCI), NIH
    National Cancer Institute (NCI), NIH

    Bethesda, MD

    Key Differentiators

    • Hematology
    • Oncology
    • Epidemiology

  • #5

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Radiation Oncology

Original Source(s)

Prognostic Factors and Treatment Outcomes for Early-Stage Hodgkin Lymphoma in Cape Town, South Africa

  • by Shakira Dawood, Brigid McMillan, Karryn Brown, Jenna Oosthuizen, David Richardson, Kudakwashe Simba, Lillian F. Andera, Jessica Opie, Katherine Antel, Stuart More, Ayesha Allie, Zainab Mohamed, Estelle Verburgh

  • November 25, 2025

Related Content

Mechanisms of kinase inhibitor resistance in subtypes of cutaneous T-cell lymphomas

Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies

Fertility preservation and subsequent reproductive outcomes in female pediatric patients with hematologic malignancies